Texas (July 8, 2013) Wax Ink has issued a Loss of Investment Interest rating for HealthStream, Inc. (Nasdaq: HSTM) based on a recent baseline equity review which placed fair value between $21-$27.
The recent close of $27.49 is approximately 115% above the fair value buy target for the stock and approximately 5% above the fair value close target for the stock. The recent close is also 10% below analysts' twelve-month $31.50 median price target for the stock.
The recent close represents a 4% increase in price since the last baseline equity review was conducted in July of 2012.
The stock currently has a trailing twelve-month PE Ratio of 53, and a PEG Ratio of 3.2 basis estimated forward earnings growth of 16.5%.
In the past 52 weeks, share prices have moved between a high of $30.76 and a low of $19.50, placing equilibrium at $24.80.
Basis the recent close, the stock is trading 12% below the 52 week high, 29% above the 52 week low, 10% above equilibrium, and has an average daily trading volume of approximately 91,000 shares.
HealthStream, Inc. provides Internet-based learning, talent management, and research solutions in the United States.
The company's competitors include National Research Corporation, SumTotal Systems, Inc., and Taleo Corporation.
Financial information that may be contained herein, is based on the company's most recent annual SEC filing for year ending December 31, 2012. All prices are per share unless otherwise noted.
Wax Ink currently has no investment position in the company mentioned in this alert.
Wax Ink is a baseline equity research company comprised of individual investors, NOT licensed or registered with ANY government agency.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.